Ушбу ишга иқтибос қилган ишлар

4 та иш

Иш: Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review

1. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology

   Jinxin Dong, Denis Nikolenko, Shuxrat Boymuradov +2

   МақолаCAR-T cell therapy researchClinical & Translational Oncology20261 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.000172

2. The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials

   Lang Wu, Jasur Rizaev, Khaled Fahmi Fawy +7

   МақолаCAR-T cell therapy researchClinical & Translational Oncology20261 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.000259

3. Epigenetic insights and innovations for overcoming barriers in CAR-T cell therapy for cancer

   Viktoria B. Poluektova, Svetlana N. Zuevskaya, Yarmatov Suvon +3

   МақолаCAR-T cell therapy researchClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.008555

4. CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy

   E. A Nemilostiva, O. A Paevskaya, Shuxrat Boymuradov +2

   МақолаPluripotent Stem Cells ResearchClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.018185